Clinical trial
Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous…
NCT00043940 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00043940 |
|---|---|
| Title | Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) |
| Official title | Anticoagulant Therapy With Bivalirudin in the Performance of PCI in Patients With Heparin-Induced Thrombocytopenia |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heparin-Induced Thrombocytopenia, Thrombosis |
| Intervention type | Drug |
| Interventions | bivalirudin |
| Enrollment | 50 |
| Start date | Apr 1, 1999 |
| Primary completion | Feb 1, 2003 |
| First posted | Aug 16, 2002 |
| Last update posted | Sep 16, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: